![Exact Sciences](https://www.ache.org/-/media/ache/corporate-partner-logos/exactsciences_web_new.png?h=367&w=1290&la=en&hash=4BD000EDE8DCCB967CC5FAA6C3C6AF12)
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype tests, Exact Sciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.
![On-Demand Webinar](https://www.ache.org/-/media/ache/about-ache/corporate-partners/icons/ondemand-webinar.png?h=49&w=615&la=en&hash=FBCD8C9F5391BBF0481068543F13EDCC)
Closing the Data Abstraction Gap To Improve Screening Quality Metrics
A common struggle in healthcare is discrepancies or gaps between the data recorded in electronic health records (EHRs) and the actual clinical information needed for accurate decision-making, reporting and analysis. Join the chief medial information officer and quality reporting specialist from NCH Healthcare System for an insightful webinar designed to equip healthcare professionals with practical strategies to enhance screening rates and improve patient outcomes. This session will focus on leveraging electronic medical record tools to streamline screening referrals, addressing data abstraction gaps and evaluating the best screening options tailored to local resources. This presentation is an excellent opportunity for healthcare providers to enhance their knowledge and skills in cancer screening, specifically ensuring they can provide the best care possible to their patients.
![On-Demand Webinar](https://www.ache.org/-/media/ache/about-ache/corporate-partners/icons/ondemand-webinar.png?h=49&w=615&la=en&hash=FBCD8C9F5391BBF0481068543F13EDCC)
Scaling a Patient-Centric Shared Decision-Making Program Across the Network to Improve Colorectal Cancer Screening Rates
National colorectal cancer (CRC) screening guidelines have recommended offering patients choice for more than five years. Experts from the American Cancer Society and U.S. Preventive Services Task Force agree that increasing overall CRC screening rates can be achieved by including patients in the decision-making process. In February 2022, Beth Israel Lahey Health identified an opportunity to pilot a patient-centric shared decision-making project to engage patients in their healthcare, improve screening rates and help alleviate burdens on providers who were faced with a significant colonoscopy backlog. Tim Carey, project manager, Beth Israel Lahey Health Performance Network, will discuss how to launch a shared decision-making pilot program and the supportive role of external collaborators to drive success. Carey will also explain the opportunities of EHR optimizations and how to measure and scale across a broad network of health systems brought together by mergers and acquisitions integrations.
About
Cancer Screening Resources
- Harnessing Digital Strategies, Interventions and Early Detection Technologies to Combat Cancer
- Colorectal Cancer Screening Quality Measures
- Colorectal Cancer Screening Guidelines
- Prioritizing Colorectal Cancer Screening: Considerations for Health Systems
- Updated Guidelines Remove Barriers for Colorectal Cancer Screening
Case Studies, Articles and Advertorials
- 3 Steps to Increase Colorectal Cancer Screening Now
- Combatting Burnout Through Collaboration, Technology Optimizations and Automation
- Increasing Colorectal Cancer(CRC) Screening at Sanitas Medical Center
- Leveraging Digital Tools to Boost Preventive Care Patient Engagement
- Using Technology to Increase Colorectal Cancer Screening Rates
- Case Study: Prioritizing Colorectal Cancer Screening at Geisinger Health System
- Reducing the Preventive Colorectal Cancer Screening Backlog Through Alignment and Optimization
- It’s Time to Elevate Genomic Oncology Testing
- The Future of Cancer Detection—Multicancer Early Detection Testing